New science may be poised to boost demand for two key products developed by Embria Health Sciences (Cedar Rapids, Iowa): eXselen, an organic, high selenium yeast created for maximum bioavailability, and EpiCor, a high immunogen metabolite, which appears to act as an immune modulator.
Embria entered the human nutrition market in August 2005, a spin off from its parent company Diamond V Mills Inc., a $40-million supplier of animal nut
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.